BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35159207)

  • 1. Breast Cancer Bone Metastasis: A Narrative Review of Emerging Targeted Drug Delivery Systems.
    Shao H; Varamini P
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges.
    Yu X; Zhu L
    Int J Nanomedicine; 2024; 19():1867-1886. PubMed ID: 38414525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release.
    Qiao H; Cui Z; Yang S; Ji D; Wang Y; Yang Y; Han X; Fan Q; Qin A; Wang T; He XP; Bu W; Tang T
    ACS Nano; 2017 Jul; 11(7):7259-7273. PubMed ID: 28692257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.
    Hussain Z; Khan JA; Murtaza S
    Crit Rev Eukaryot Gene Expr; 2018; 28(2):163-175. PubMed ID: 30055543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutics targeting the metastatic breast cancer bone microenvironment.
    Ihle CL; Wright-Hobart SJ; Owens P
    Pharmacol Ther; 2022 Nov; 239():108280. PubMed ID: 36116682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-Targeted Nanoplatform Combining Zoledronate and Photothermal Therapy To Treat Breast Cancer Bone Metastasis.
    Sun W; Ge K; Jin Y; Han Y; Zhang H; Zhou G; Yang X; Liu D; Liu H; Liang XJ; Zhang J
    ACS Nano; 2019 Jul; 13(7):7556-7567. PubMed ID: 31259530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular signature of breast cancer metastasis to bone.
    Bahrami T; Mokmeli S; Hossieni H; Pourpaknia R; Makani Z; Salmaninejad A; Estiar MA; Hossieni A; Farshbaf A
    Anticancer Drugs; 2016 Oct; 27(9):824-31. PubMed ID: 27384592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
    Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
    J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapeutic targets in breast cancer bone metastasis.
    Rose AA; Siegel PM
    Future Oncol; 2010 Jan; 6(1):55-74. PubMed ID: 20021209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications.
    Ebrahimnejad P; Mohammadi Z; Babaei A; Ahmadi M; Amirkhanloo S; Asare-Addo K; Nokhodchid A
    Crit Rev Ther Drug Carrier Syst; 2024; 41(1):35-84. PubMed ID: 37824418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
    Subia B; Dey T; Sharma S; Kundu SC
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the currently available and future chemotherapy for treating bone metastases in breast cancer patients.
    Oruç Z; Kaplan MA; Arslan Ç
    Expert Opin Pharmacother; 2018 Aug; 19(12):1305-1316. PubMed ID: 30129373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
    Yang Y; Zhao Z; Xie C; Zhao Y
    Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
    Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC
    J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.
    Katsumi H; Yamashita S; Morishita M; Yamamoto A
    Chem Pharm Bull (Tokyo); 2020; 68(7):560-566. PubMed ID: 32611993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of targeted drug delivery system for the treatment of bone metastasis.
    Vinay R; KusumDevi V
    Drug Deliv; 2016; 23(1):21-9. PubMed ID: 24839990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.
    Calixto G; Bernegossi J; Fonseca-Santos B; Chorilli M
    Int J Nanomedicine; 2014; 9():3719-35. PubMed ID: 25143724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Maturitas; 2012 Sep; 73(1):19-26. PubMed ID: 22402026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.